ישראל - עברית - Ministry of Health

ביו מד פארמה בע"מ - כלל האוכלוסיה - חבישות לספיחת הפרשות קיצוניות

ישראל - עברית - Ministry of Health

meridian bioscience isreal ltd., israel - urea- c 13 - טבליה - urea- c 13 75 mg - intended for use in the qualitative detection of urease associated with h. pylory in the human stomach and as an aid in the initial diagnosis and post treatment monitoring of h. pylory infection in adult patients.

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - bifonazole; urea - משחה - urea 40 %; bifonazole 1 % - bifonazole - bifonazole - for nail stripping and antifungal treatment of fungal infections of the finger nails and toe nails.

ישראל - עברית - Ministry of Health

trupharm marketing 1985 ltd. - urea hydrogen peroxide - טיפות - urea hydrogen peroxide 5 % - hydrogen peroxide - hydrogen peroxide - an aid for the removal of hardened ear wax.

ישראל - עברית - Ministry of Health

perrigo israel pharmaceuticals ltd - bifonazole; urea - משחה - bifonazole 1 %; urea 40 % - imidazole and triazole derivatives - for nail stripping and antifungal treatment of fungal infections of the finger nails and toe nails.

ישראל - עברית - Ministry of Health

vitamed pharmaceutical industries ltd - diclofenac sodium - ג'ל - diclofenac sodium 1 %w/w - diclofenac - diclofenac - local treatment of rheumatic diseases, non infected inflammations and pain.

ישראל - עברית - Ministry of Health

נגרין סופיה - הזנת העור

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - liraglutide - תמיסה להזרקה - liraglutide 6.0 mg/ml - liraglutide - liraglutide - for the treatment of adults with type 2 diabetes mellitus to achieve glycemic control : in combination with : - metformin or a sulphonylurea, in patients with insufficient glycemic control despite maximal tolerated dose of monotherapy with mentformin or sulphonylurea. - metformin and sulphonylurea or metformin and a thiazolidinedione in patients with insufficient glycemic control despite dual therapy.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - exenatide - אבקה וממס להכנת תרחיף להזרקה - exenatide 2 mg - exenatide - exenatide - bydureon is indicated for treatment of type 2 diabetes mellitus in combination with : • metformin• sulphonylurea• metformin and sulphonylureain adults who have not achieved adequate glycaemic control on maximally tolerated doses of these oral therapies.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 5000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative